First Turn Management, LLC
- SEC CIK
- 0001993440
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 35
- 0 vs. Q1 2025
- Portfolio value
- $536.0M
- +$40.0M (+8.1%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| INSMINSMED Inc | COM PAR $.01 | 372,672 | $37.5M | 7.0% | −28,957−7.2% | Reduced | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 309,988 | $29.3M | 5.5% | −125,397−28.8% | Reduced | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 527,540 | $26.8M | 5.0% | +24,526+4.9% | Added | History |
| NUVLNuvalent, Inc. | COM | 320,798 | $24.5M | 4.6% | −11,129−3.4% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 43,953 | $24.2M | 4.5% | +2,042+4.9% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 551,684 | $23.8M | 4.4% | −105,015−16.0% | Reduced | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 134,687 | $23.2M | 4.3% | +21,409+18.9% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 660,617 | $20.7M | 3.9% | −22,834−3.3% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 2,009,923 | $20.4M | 3.8% | −17,507−0.9% | Reduced | History |
| NTRANatera, Inc. | COM | 118,130 | $20.0M | 3.7% | −21,812−15.6% | Reduced | History |
| ADMAAdma Biologics, Inc. | COM | 1,092,361 | $19.9M | 3.7% | +525,416+92.7% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 32,305 | $17.6M | 3.3% | +10,196+46.1% | Added | History |
| PODDInsulet Corp | Stock | 51,408 | $16.2M | 3.0% | +2,058+4.2% | Added | History |
| TGTXTG Therapeutics, Inc. | COM | 447,884 | $16.1M | 3.0% | +47,240+11.8% | Added | History |
| IRONDisc Medicine, Inc. | COM | 299,464 | $15.9M | 3.0% | +299,464 | New | History |
| GHGuardant Health, Inc. | COM | 302,307 | $15.7M | 2.9% | −13,430−4.3% | Reduced | History |
| MRUSMerus N.V. | COM | 292,964 | $15.4M | 2.9% | −170,996−36.9% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 415,591 | $15.3M | 2.9% | +75,482+22.2% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 144,400 | $15.1M | 2.8% | +26,221+22.2% | Added | History |
| BSXBoston Scientific Corp | Stock | 138,834 | $14.9M | 2.8% | −39,322−22.1% | Reduced | History |
| ACLXArcellx, Inc. | COMMON STOCK | 215,223 | $14.2M | 2.6% | +215,223 | New | History |
| APGEApogee Therapeutics, Inc. | COM | 311,490 | $13.5M | 2.5% | +81,815+35.6% | Added | History |
| RDNTRadNet, Inc. | COM | 197,759 | $11.3M | 2.1% | +40,144+25.5% | Added | History |
| JANXJanux Therapeutics, Inc. | COM | 447,420 | $10.3M | 1.9% | +17,257+4.0% | Added | History |
| ELVNEnliven Therapeutics, Inc. | COM | 509,987 | $10.2M | 1.9% | −25,105−4.7% | Reduced | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 521,097 | $9.44M | 1.8% | +521,097 | New | History |
| HQYHealthequity, Inc. | COM | 80,880 | $8.47M | 1.6% | −3,086−3.7% | Reduced | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 455,953 | $7.96M | 1.5% | −213,057−31.8% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 309,666 | $7.30M | 1.4% | −313,946−50.3% | Reduced | History |
| SLNOSoleno Therapeutics Inc | COM | 86,332 | $7.23M | 1.3% | +57,217+196.5% | Added | History |
| HROWHarrow, Inc. | COM | 228,761 | $6.99M | 1.3% | +39,932+21.1% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 114,554 | $6.11M | 1.1% | +114,554 | New | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 17,879 | $5.83M | 1.1% | +17,879 | New | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 214,138 | $2.42M | 0.5% | +214,138 | New | History |
| BBNXBeta Bionics, Inc. | COM | 157,194 | $2.29M | 0.4% | +157,194 | New | History |
Sold out since Q1 2025 (7)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| SWTXSpringWorks Therapeutics, Inc. | COM | 304,076 | $13.4M | 2.7% | History |
| GKOSGLAUKOS Corp | COM | 136,241 | $13.4M | 2.7% | History |
| EXASExact Sciences Corp | COM | 300,909 | $13.0M | 2.6% | History |
| PCVXVaxcyte, Inc. | COM | 276,905 | $10.5M | 2.1% | History |
| BPMCBlueprint Medicines Corp | COM | 92,033 | $8.15M | 1.6% | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 179,196 | $7.00M | 1.4% | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 71,775 | $2.72M | 0.5% | History |